Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation

scientific article published on 01 March 2000

Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID15580726

P2093author name stringNational Vaccine Advisory Committee
R F Breiman
A S Postema
P433issueRR-1
P407language of work or nameEnglishQ1860
P921main subjectmass vaccinationQ70477194
P304page(s)1-13
P577publication date2000-03-01
P1433published inMorbidity and Mortality Weekly Report: Recommendations and ReportsQ23930023
P1476titleAdult immunization programs in nontraditional settings: quality standards and guidance for program evaluation
P478volume49

Reverse relations

cites work (P2860)
Q37955313A multi-season national estimate of adult influenza vaccination by U.S. office-based pediatricians, 2006-2011.
Q35606837A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011
Q37342230Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage
Q38974910Community pharmacies as sites of adult vaccination: A systematic review
Q64126657Engaging Communities to Reach Immigrant and Minority Populations: The Minnesota Immunization Networking Initiative (MINI), 2006-2017
Q37093936High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma
Q39681401Immunization programs in non-traditional settings.
Q36830435Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease
Q35194841Influenza vaccination of parents and guardians by US pediatricians
Q81359091Lack of immunization documentation in Minnesota refugees: challenges for refugee preventive health care
Q47388078Linking Time-Use Data to Explore Health Outcomes: Choosing to Vaccinate Against Influenza.
Q43458355Military healthcare providers reporting of adverse events following immunizations to the vaccine adverse event reporting system
Q43612591National and state-specific estimates of place of influenza vaccination among adult populations - United States, 2011-12 influenza season
Q34545474Novel virus, atypical risk group: understanding young adults in college as an under-protected population during H1N1 2009.
Q30228968Pandemic influenza planning in the United States from a health disparities perspective
Q30274913Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee
Q41571376Pneumococcal vaccination among adults with work-related asthma
Q47564096Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists
Q36827457State Law and Standing Orders for Immunization Services
Q36272135Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention
Q37010145The growth of retail clinics in vaccination delivery in the U.S.
Q34663511The relationship between influenza vaccination habits and location of vaccination
Q48447082The role of community pharmacy-based vaccination in the USA: current practice and future directions
Q35081598Using implementation intentions prompts to enhance influenza vaccination rates
Q37157659Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience
Q36830439When Should Therapy for Inflammatory Bowel Disease Be Stopped?
Q50739777[EVAN-65 project: evaluation of the effectiveness of pneumococcus vaccination in the elderly population over 65].

Search more.